par Piccart-Gebhart, Martine
Référence Anti-cancer drugs, 6 Suppl 4, page (7-11)
Publication Publié, 1995-07
Article révisé par les pairs
Titre:
  • Docetaxel: a new defence in the management of breast cancer.
Auteur:Piccart-Gebhart, Martine
Informations sur la publication:Anti-cancer drugs, 6 Suppl 4, page (7-11)
Statut de publication:Publié, 1995-07
Sujet CREF:Sciences bio-médicales et agricoles
MeSH keywords:Antineoplastic Agents -- therapeutic use
Antineoplastic Agents, Phytogenic -- adverse effects
Antineoplastic Agents, Phytogenic -- therapeutic use
Breast Neoplasms -- drug therapy
Breast Neoplasms -- mortality
Breast Neoplasms -- pathology
Clinical Trials, Phase II as Topic
Doxorubicin -- therapeutic use
Female
Humans
Liver Neoplasms -- drug therapy
Liver Neoplasms -- secondary
Middle Aged
Multicenter Studies as Topic
Neoplasm Staging
Paclitaxel -- adverse effects
Paclitaxel -- analogs & derivatives
Paclitaxel -- therapeutic use
Survival Rate
Taxoids
Note générale:Comparative Study
Journal Article
Review
SCOPUS: re.j
Langue:Anglais
Identificateurs:urn:issn:0959-4973
info:scp/0029563129
info:pmid/8745348